Study finds similar pathogenic pathways in AMD and some cancers

News
Article

The South Korean study found that those with age-related macular degeneration may be more at risk of developing some cancers, like renal and thyroid.

Older woman with headwrap hugging daughter Image Credit: AdobeStock/AfricaStudio

Image Credit: AdobeStock/AfricaStudio

Junhee Park, MD, and associates reported a possible association between several cancers and age-related macular degeneration (AMD) that they identified in a population-based cohort study.1 Park is from the Family Medicine Department, Samsung Medical Center, Seoul, South Korea.

The investigators believe that AMD and cancer may have similar risk factors in common, thus suggesting that they have common pathogenic pathways.

They analyzed 10 years of data from the Korean National Health Insurance Service database (2009-2019). This included individuals who had participated in a national health screening program in 2009. The participants were categorized based on the presence of AMD and visual disability.

The cohort included over 4 million patients, of whom 51596 had AMD and of those with AMD, 3683 were visually disabled. The mean patient follow-up was 9.6 years, Park reported.

Specifically, the overall cancer risk was generally null. “However, the risks of hypervascular cancer such as thyroid cancer (adjusted hazard ratio [HR] 1.10, 95% confidence interval [CI ]1.00 to 1.20) and renal cancer (adjusted HR 1.16, 95% CI 1.00 to 1.33) were higher and the risk of stomach cancer (adjusted HR 0.89, 95% CI 0.84 to 0.94) was lower in the AMD group than in the non-AMD group.

Park and colleagues concluded, “This study demonstrated a possible association between AMD and several cancers. The increased risks of renal and thyroid cancer among patients with AMD could indicate that AMD is associated with hypervascular cancer. Further studies in which additional databases are used and the underlying detailed mechanisms evaluated are needed to validate our results.”

Reference:
  1. Park J, Jung W, Han K, et al. Association between age-related macular degeneration and risk of incident cancer. Br J Ophthalmol. 2024; published online February 28; https://doi.org/10.1136/bjo-2023-323874
Recent Videos
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Optometrists reflect on their residency experiences and provide advice to current residents.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
© 2025 MJH Life Sciences

All rights reserved.